Neoplasms, Germ Cell and Embryonal: all 295 studies
Page 2 of 3. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.
- Retrospective Study of Germ Cell Tumors of the Central Nervous SystemActive, not recruitingNCT05836701
- Sodium Thiosulfate Otoprotection During Salvage Cisplatin TherapySuspendedNCT05756660Early Phase 1
- CD30 CAR for CD30+ NSGCTCompletedNCT05634785Phase 2
- Vorasidenib Expanded Access ProgramApproved for marketingNCT05592743
- A Study of DS-9606a in Patients With Advanced Solid TumorsTerminatedNCT05394675Phase 1
- Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in ChildrenStatus unknownNCT05179850
- Exercise in Testicular Germ Cell Cancer SurvivorsActive, not recruitingNCT05063760Not applicable
- Surveillance of Association of Immune Status and Prognosis of CNS Germ Cell Tumor SurvivorsStatus unknownNCT04909307
- A Phase II Trial of Cabozantinib With Patients With Refractory GCTsCompletedNCT04876456Phase 2
- External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCStatus unknownNCT04697446
- Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma PatientsCompletedNCT04657315Phase 1/2
- Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWithdrawnNCT04648826Phase 1/2
- Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor.Status unknownNCT04581265Phase 2
- B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT04483778Phase 1
- A Study of miRNA 371 in Patients With Germ Cell TumorsActive, not recruitingNCT04435756
- Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With rGCC: A Pilot StudyWithdrawnNCT04402593Not applicable
- Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell TumoursCompletedNCT04122430
- Exploratory Study of Molecular Characterization in Patients With Metastatic Germ Cell Tumours Refractory/Resistant to Platinum TreatmentStatus unknownNCT03980587
- Rolapitant Plus Olanzapine in Multiday Cisplatin ChemotherapyWithdrawnNCT03960151Phase 2
- Disulfiram and Cisplatin in Refractory TGCTs.CompletedNCT03950830Phase 2
- Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell TumorsStatus unknownNCT03868176
- Ex Vivo Drug Sensitivity Testing and Mutation ProfilingCompletedNCT03860376
- Evaluating Structural and Functional Changes of Brain by fMRI and DTI in Patients With Intracranial Germ Cell TumorsStatus unknownNCT03771625
- Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell TumorsWithdrawnNCT03726281Phase 2
- EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsCompletedNCT03638167Phase 1
- EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT03618381Phase 1
- HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsActive, not recruitingNCT03500991Phase 1
- Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)Status unknownNCT03476070
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- Role of Axumin PET Scan in Germ Cell TumorCompletedNCT03426865
- Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of ChemotherapyActive, not recruitingNCT03418844Not applicable
- Avelumab in Refractory Testicular Germ Cell Cancer.CompletedNCT03403777Phase 2
- Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell TumorsActive, not recruitingNCT03158064Phase 2
- Durvalumab Alone or With Tremelimumab in Refractory Germ Cell TumorsTerminatedNCT03081923Phase 2
- Secured Access to Pembrolizumab for Patients With Selected Rare Cancer TypesCompletedNCT03012620Phase 2
- Multicenter Database of Patients With Germ Cell TumorCompletedNCT02863003
- Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell CancerCompletedNCT02860819Phase 2
- Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary MetastasectomyWithdrawnNCT02839694Phase 1
- Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)Status unknownNCT02797626Phase 2
- Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell TumorStatus unknownNCT02784054Phase 2
- Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late RelapseCompletedNCT02679950
- Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell TumorCompletedNCT02677727
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingNCT02574728Phase 2
- A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid TumorsTerminatedNCT02536183Phase 1
- Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell TumorCompletedNCT02533765Phase 2
- Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell CancerCompletedNCT02433197Not applicable
- Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell TumorsCompletedNCT02429466Phase 1
- First Line TIP in Poor Prognosis TGCTs.CompletedNCT02414685Phase 2
- Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsActive, not recruitingNCT02375204Phase 3
- A Pilot RCT of the PRISM Intervention for AYAs With CancerCompletedNCT02340884Phase 2
- Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of ChemotherapyCompletedNCT02317393Phase 2
- Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor SurvivorsCompletedNCT02303015
- Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell TumorsCompletedNCT02161692Phase 2
- A Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures and the Risk of Testicular Germ Cell TumorCompletedNCT02109926
- A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and AdolescentCompletedNCT02104986Phase 2
- MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid TumorsCompletedNCT02076906Phase 1
- Salvage Chemotherapy for Poor Prognosis Germ Cell TumorsStatus unknownNCT01966913Phase 1/2
- Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian CancerWithdrawnNCT01927393Not applicable
- Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell TumorsActive, not recruitingNCT01873326Phase 2
- Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell TumorsCompletedNCT01851200Phase 2
- A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor PrognosisCompletedNCT01782339Phase 2
- Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
- Pazopanib in Advanced and Cisplatin-resistant Germ Cell TumorsCompletedNCT01743482Phase 2
- Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis TumoursCompletedNCT01726374Phase 3
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedNCT01625351Phase 1
- Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal TumorsCompletedNCT01572467
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian CancerTerminatedNCT01494012Phase 1
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaCompletedNCT01484015Phase 1
- Everolimus in Refractory Testicular Germ Cell CancerCompletedNCT01466231Phase 2
- Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor ControlsActive, not recruitingNCT01453660
- DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or SiblingsCompletedNCT01434355
- Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor ProgressionCompletedNCT01433224
- Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell TumorsStatus unknownNCT01424839Phase 4
- Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian CancerCompletedNCT01322802Phase 1
- Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumTerminatedNCT01313429Phase 1
- Everolimus for Patients With Relapsed/Refractory Germ Cell CancerCompletedNCT01242631Phase 2
- High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line TherapyStatus unknownNCT01172912Phase 2
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346Not applicable
- Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic CancerStatus unknownNCT01087268Phase 3
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyCompletedNCT01080521
- Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantTerminatedNCT01077440
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell TumorsActive, not recruitingNCT01049230Not applicable
- Genomic Structural Variation in Cancer SusceptibilityActive, not recruitingNCT00996710
- Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
- Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell TumorsStatus unknownNCT00983398Phase 1/2
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeTerminatedNCT00946283Not applicable
- Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00929903Phase 1
- Blood Samples From Patients on a Clinical Trial to CINV During HSCTTerminatedNCT00900068
- Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic CancerTerminatedNCT00899132
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous SystemCompletedNCT00867178Phase 1
- Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad PrognosisCompletedNCT00864318Phase 2
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
- Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorCompletedNCT00638898Phase 1
- Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinCompletedNCT00611962Phase 2
- Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the TesticleStatus unknownNCT00589537Phase 3